Sponsored by François-Xavier Bagnoud Center, School of
Nursing, University of Medicine and Dentistry of New Jersey
and UMDNJ-Center for Continuing and Outreach Education.
This activity is supported by an educational grant from the New Jersey Department of Health and Senior Services (NJDHSS)—Division of HIV, STD and TB Services, through an MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
Statement of Need
Most clinicians are comfortable taking a sexual history when they perceive the presenting complaint as directly relating to a sexual problem; however, many fewer used sexual history-taking skills in a more proactive way, as part of routine and preventative healthcare. Many healthcare providers are concerned about their ability to take an appropriate sexual history, however skilled and confident they may be at taking a standard history.
Physical exams of the genital region are not routine, and diagnosis of STDs is usually based on either patient description of symptoms or routine screening. If routine screening is not conducted, many cases of early STDs may be missed and progress to more serious stages. There is no consistent requirement to confirm that these physical exams have been conducted. Some clinicians have yet to update their practice in line with the current STD Treatment guidelines, instead using treatment regimens that may be outdated.
Healthcare providers play an important role in conducting screening and follow-up,and in patient education and counseling. Healthcare providers need to update their knowledge of effective screening practices and complications of treatment for STDs. This will improve the care of patients with and without HIV infection, and reduce transmission of STDs and HIV to uninfected individuals.
This activity is designed for physicians, nurses, social workers, and other health care professionals in New Jersey who are involved in the care of persons at risk for STDs.
Method of Participation
Participants should read the learning objectives, review the activity in its entirety, and then complete the self-assessment test, which consists of a series of multiple-choice questions. Upon completing this activity as designed, achieving a passing score of 70% or more on the self-assessment test and submitting a course evaluation, participants will have access to an online printable credit statement.
Estimated time to complete this activity as designed is 1.35 hours for nurses, and 1.5 hours for physicians.
Upon completion of this activity, participants should be able to:
- Recognize the importance of taking a thorough sexual history in an appropriate and nonjudgmental manner and describe how to use understandable and normalizing language.
- Explain the importance of integrating counseling messages on the prevention of sexually transmitted diseases, including HIV and hepatitis, into practice.
- Implement current CDC guidelines in the diagnosis, treatment, partner follow-up, and reporting of sexually transmitted diseases.
Activity Director(s)/CME Academic Advisor(s)
Patricia Kloser, MD, MPH,
Professor of Medicine, UMDNJ-New Jersey Medical School and UMDNJ-School of Public Health
Sindy Paul, MD, MPH, FACPM, Medical Director, Division of HIV, STD and TB Services, New Jersey Department of Health and Senior Services
Kimi Nakata, MSW, MPH, UMDNJ-CCOE-Division of AIDS Education Program Supervisor and Editor, NJ AIDSLine (until February 2012)
Virginia Allread, MPH, Editor NJ AIDSLine (February 2012 to present) and Director of Global Programs, FXB Center, School of Nursing, UMDNJ
Joanne Phillips, MSN, PNP, BSN, Education Specialist, FXB Center, School of Nursing, UMDNJ
Renee Powell, MS, RN, Clinical Coordinator, Quality Management, FXB Center, School of Nursing, UMDNJ
Elizabeth Ward, MSJ, Director, CME Compliance and Administration, UMDNJ-CCOE
Brenda Christian, Med, PA-C, UMDNJ-CCOE, Director, Division of AIDS Education (until February 2012)
Bonnie Richards, DO, BSN, Family Medicine Resident, Aria Health, Philadelphia, Pennsylvania
Patricia Mason, BS, PHA Program Manager, New Jersey Department of Health and Senior Services, Sexually Transmitted Disease Program, Trenton, New Jersey
Sindy Paul, MD,MPH, FACPM, Medical Director, Division of HIV, STD and TB Services
Credit is no longer available for this activity.
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, UMDNJ-CCOE has resolved all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers. This activity was peer-reviewed for relevance, accuracy of content and balance of presentation by Patricia Kloser, MD, MPH; Shin-Pung Polly Jen, PharmD, BCPS; John J. Faragon, PharmD; Joanne Phillips, RN, MS; and Renee Powell, MS, RN.
This activity was pilot-tested for time required for participation by Bonnie R. Abedini, MSN, RN; Jojy Cheriyan, MD, MPH, MPhil; Anna M. Haywood, RN, MSN; Mary C. Krug, RN, MSN, APN; Shobha Swaminathan, MD; and Kara Winslow, BSN, RN.
In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/ device not yet approved.
Dr. Swaminathan disclosed the following relevant financial relationships: Member, Scientific Advisory Board: Gilead, Merck. There were no other relevant financial relationships to disclose reported by the activity director, authors, planning committee members, peer reviewers or field testers.
Off-Label Usage Disclosure
This activity contains information of commercial products/ devices that are unlabeled for use or investigational uses of products not yet approved. It mentions three diagnostic tests that are not yet FDA approved: NAATs for testing of rectal or oropharyngeal swab specimens for chlamydia; NAAT testing of specimens from the rectum, pharynx, or conjunctiva for gonorrhea; and wet preparation and microscopic exam testing for trichomoniasis.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDHSS – Division of HIV, STD and TB Services, any manufacturer of pharmaceuticals or devices, or UMDNJ. It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
Copyright © 2012 UMDNJ
All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ.
Please direct CE related or technical questions to UMDNJ at 973-972-4267 or email email@example.com.